In transgenic mice overexpressing Stat5 or a constitutively activated Stat5 variant (STAT5ca), we show for the first time that parity is required for the development of tumors in postestropausal females. Tumors were detected in glands of multiparous transgenic female mice after latency period of 14 months, but rarely in their age-matched virgin (AMV) counterparts. This period was not affected by distinguishable tumor pathologies and was not dependent upon transgenic Stat5 variant. To associate Stat5 deregulation, parity and the postestropausal tumor occurrence with mammary cancer formation, the activities of endogenous and transgenic Stat5 were measured in the glands of aged multiparous and AMV females. No differences in phosphorylated Stat5 (pStat5) levels were found between the 2 cohorts. However, promoter sequences comprising the Stat5 binding sites from the cyclin D1 or the bcl-x genes associate differentially with acetylated histone H4 in aged multiparous and AMV STAT5ca transgenic females. Individual epithelial cells varied greatly with respect to the presence of nuclear pStat5. A small subset of epithelial cells, in which pStat5 and cyclin D1 were co-expressed, was exclusively present in the multiparous glands. Changes in chromatin structure might persist past the reproductive life time of the multiparous mice and contribute to the transcription of the cyclin D1 gene by activated Stat5. This may cause the detectable expression of cyclin D1 and add to the process of tumorigenesis. ' 2007 Wiley-Liss, Inc.Key words: transgenic mice; mammary gland; breast; Stat5; cancer; parity Epidemiological studies have established a correlation between parity and the incidence of breast cancer in women.1-3 Parity has a protective effect, which depends on an early age of full-term pregnancy and is augmented by the total number of pregnancies. 4,5 In contrast, first pregnancy in women at their 30s is considered a life time risk factor. 2,6 A transient increase in risk for breast cancer after delivery has also been found and augmented in women at their 30s. 7,8 The diversity between the protective and inductive effects of parity on breast cancer was mainly associated with the be-directional double edged action of sex steroid hormones. Estrogen and progesterone could induce breast cancer by growth promoting effect on premalignant or preexisting malignant cells and protect from the disease by exerting persistent changes during a critical period of adolescence with long terms effects on cell proliferation and stem cells population.9-14 The detailed mechanisms regulating the action of sex steroid hormones remain elusive, but most likely involve signaling pathways that govern the balance between apoptosis, proliferation and differentiation. Recently, the mammary microenvironment was also associated with the transient increase in breast cancer risk. It was proposed that remodeling of the mammary gland during involution induces proinflammatory and wound-healing signals that are pro-oncogenic and contribute to cancer promotion and p...